Companies · Healthcare · 🇮🇳

Zydus Lifesciences Ltd.

ZYDUSLIFE · NSE · Healthcare · ₹1,120 a share (close of 21 Aug 2026)

Every figure on this page comes from documents Zydus Lifesciences Ltd. filed with the exchange, and each one was checked against the document itself before publication. What could not be verified is not here.

The quarters, as filed
QuarterRevenueYoYNet profit YoYNet margin
Mar 2026₹7,434 cr+18.2%₹1,272 cr+8.7%17.1%
Dec 2025₹6,780 cr+32.3%₹1,042 cr+1.8%15.4%
Jun 2025₹6,467 cr₹1,467 cr22.7%
Mar 2025₹6,290 cr₹1,171 cr18.6%
Dec 2024₹5,124 cr₹1,024 cr20.0%
Filing timeline — what the company told the exchange

Your desk can read every filing this company makes — before the market opens.

Watch it, and each morning it files something you get the checked numbers, the sources, and red-flag alerts when the quiet numbers move — pledges, ratings, resignations. Ask by name any evening and it is read overnight.

Start free — first week on us →
₹99/month after · research, not investment advice · cancel any time

Data from documents filed with the exchanges, checked against the documents themselves. This page states facts and is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI and verified against filed documents. Terms, disclosures and grievances